Jorg Petersen

Summary

Publications

  1. doi request reprint Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study
    Jorg Petersen
    Liver Unit, Ifi Institute for Interdisciplinary Medicine, Asklepios Klinik St Georg Hamburg, Germany
    J Hepatol 56:520-6. 2012
  2. ncbi request reprint [Hepatitis B in clinical practice]
    Jorg Petersen
    Leberzentrum Hamburg, IFI Institut für Interdisziplinäre Medizin an der Asklepios Klinik St Georg, Hamburg
    Med Monatsschr Pharm 34:402-14; quiz 415-6. 2011
  3. doi request reprint The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
    Tassilo Volz
    Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Hepatol 58:861-7. 2013
  4. doi request reprint Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection
    Katja Giersch
    I Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Hepatol 60:538-44. 2014
  5. doi request reprint Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Jorg Petersen
    Ifi Institute for Interdisciplinary Medicine, Asklepios Klinik St Georg, Hamburg, Germany
    Expert Rev Gastroenterol Hepatol 6:683-93; quiz 694. 2012
  6. doi request reprint Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?
    Jorg Petersen
    IFI Institute at the Asklepios Klinik St Georg Hamburg, University of Hamburg, Hamburg, Germany
    Liver Int 35:114-20. 2015
  7. doi request reprint Experimental models and therapeutic approaches for HBV
    Maura Dandri
    Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Semin Immunopathol 35:7-21. 2013

Collaborators

Detail Information

Publications7

  1. doi request reprint Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study
    Jorg Petersen
    Liver Unit, Ifi Institute for Interdisciplinary Medicine, Asklepios Klinik St Georg Hamburg, Germany
    J Hepatol 56:520-6. 2012
    ..Aim of this study was to investigate the efficacy and safety of entecavir plus tenofovir combination in 57 CHB partial responders or multidrug resistant patients...
  2. ncbi request reprint [Hepatitis B in clinical practice]
    Jorg Petersen
    Leberzentrum Hamburg, IFI Institut für Interdisziplinäre Medizin an der Asklepios Klinik St Georg, Hamburg
    Med Monatsschr Pharm 34:402-14; quiz 415-6. 2011
    ..The recommendations of these guidelines are delineated. Most importantly the management of hepatitis B remains complicated and needs very experienced hepatologists...
  3. doi request reprint The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
    Tassilo Volz
    Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Hepatol 58:861-7. 2013
    ..We aimed at investigating the ability of the lipopeptide Myrcludex-B to block HBV spreading post-infection...
  4. doi request reprint Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection
    Katja Giersch
    I Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Hepatol 60:538-44. 2014
    ..This study investigated whether HDV could persist intrahepatically in the absence of HBV in vivo and whether infectious HDV could subsequently be released following HBV super-infection...
  5. doi request reprint Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Jorg Petersen
    Ifi Institute for Interdisciplinary Medicine, Asklepios Klinik St Georg, Hamburg, Germany
    Expert Rev Gastroenterol Hepatol 6:683-93; quiz 694. 2012
    ..Recent findings on whether and under what circumstances long-term therapy of CHB might be stopped are also discussed...
  6. doi request reprint Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?
    Jorg Petersen
    IFI Institute at the Asklepios Klinik St Georg Hamburg, University of Hamburg, Hamburg, Germany
    Liver Int 35:114-20. 2015
    ....
  7. doi request reprint Experimental models and therapeutic approaches for HBV
    Maura Dandri
    Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Semin Immunopathol 35:7-21. 2013
    ....